Characterization of inflammatory bowel disease with urinary metabolic profiling.

Characterization of inflammatory bowel disease with urinary metabolic profiling.

OBJECTIVES: Distinguishing between the inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) is important for both management and prognostic reasons. Discrimination using noninvasive techniques could be an adjunct to conventional diagnostics. Differences have been...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Williams, H, Cox, I, Walker, D, North, B, Patel, V, Marshall, SE, Jewell, D, Ghosh, S, Thomas, H, Teare, J, Jakobovits, S, Zeki, S, Welsh, K, Taylor-Robinson, S, Orchard, T
Format:	Journal article
Język:	English
Wydane:	2009

Podobne zapisy

Peripheral arthritis and inflammatory bowel disease.
od: Wordsworth, P, i wsp.
Wydane: (1998)

Peripheral arthropathies in inflammatory bowel disease - Reply
od: Orchard, T, i wsp.
Wydane: (1999)

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.
od: Orchard, T, i wsp.
Wydane: (2002)

HLA genes are important phenotype determining genes in the peripheral arthropathies of inflammatory bowel disease (IBD).
od: Orchard, T, i wsp.
Wydane: (1998)

Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
od: Orchard, T, i wsp.
Wydane: (1997)

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
od: Fraser, A, i wsp.
Wydane: (2002)

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.
od: Orchard, T, i wsp.
Wydane: (2000)

Genetics of inflammatory bowel disease: a reappraisal.
od: Orchard, T, i wsp.
Wydane: (2000)

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history.
od: Orchard, T, i wsp.
Wydane: (1998)

Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history.
od: Orchard, T, i wsp.
Wydane: (1997)

Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings.
od: Orchard, T, i wsp.
Wydane: (1997)

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
od: Fraser, A, i wsp.
Wydane: (2002)

High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility.
od: Ahmad, T, i wsp.
Wydane: (2002)

MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy.
od: Orchard, T, i wsp.
Wydane: (2001)

Immunology of inflammatory bowel disease.
od: Jewell, D, i wsp.
Wydane: (1985)

Is interleukin-6 important in inflammatory bowel disease?
od: Koss, K, i wsp.
Wydane: (2000)

Immunology of inflammatory bowel disease.
od: Hodgson, H, i wsp.
Wydane: (1987)

Salicylates for inflammatory bowel disease.
od: Travis, S, i wsp.
Wydane: (1994)

Proceedings: Complement in inflammatory bowel disease.
od: Hodgson, H, i wsp.
Wydane: (1975)

Immunology of inflammatory bowel disease--an update.
od: Jewell, D
Wydane: (1995)

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
od: Jakobovits, S, i wsp.
Wydane: (2007)

Genes of the HLA region are important in determining clinical phenotype in the peripheral arthropathies of inflammatory bowel disease (IBD).
od: Orchard, T, i wsp.
Wydane: (1998)

The immunology of inflammatory bowel disease.
od: Lowes, JR, i wsp.
Wydane: (1990)

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
od: Satsangi, J, i wsp.
Wydane: (2000)

Atopy in inflammatory bowel disease.
od: Mee, A, i wsp.
Wydane: (1979)

Cytokines and inflammatory bowel disease.
od: Radford-Smith, G, i wsp.
Wydane: (1996)

The association of autoimmune disorders with inflammatory bowel disease.
od: Snook, J, i wsp.
Wydane: (1989)

Genetics of inflammatory bowel disease--an update.
od: van Heel, D, i wsp.
Wydane: (2001)

Cytokine production in inflammatory bowel disease.
od: Satsangi, J, i wsp.
Wydane: (1994)

Macrophage activity in inflammatory bowel disease.
od: Mahida, Y, i wsp.
Wydane: (1990)

The genetics of inflammatory bowel disease.
od: Satsangi, J, i wsp.
Wydane: (1997)

Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.
od: Mahida, Y, i wsp.
Wydane: (1988)

The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.
od: Hodgson, H, i wsp.
Wydane: (1978)

Clinical patterns of familial inflammatory bowel disease.
od: Satsangi, J, i wsp.
Wydane: (1996)

The role of cytokines in inflammatory bowel disease.
od: Radford-Smith, G, i wsp.
Wydane: (1994)

Factors inducing relapse in inflammatory bowel disease.
od: Mee, A, i wsp.
Wydane: (1978)

Immunoregulatory mechanisms in nonspecific inflammatory bowel disease.
od: Strickland, R, i wsp.
Wydane: (1983)

Cyclosporin for the treatment of severe inflammatory bowel disease.
od: Baker, K, i wsp.
Wydane: (1989)

Genetics of inflammatory bowel disease.
od: Satsangi, J, i wsp.
Wydane: (1998)

Genetics of inflammatory bowel disease.
od: Satsangi, J, i wsp.
Wydane: (1994)